A Randomized, Placebo‐Controlled Trial of Hydroxychloroquine in Incomplete Lupus
Although the Study of Antimalarials in Incomplete Lupus Erythematosus (SMILE) did not show effects of HCQ on ILE progression, the results offer insights into SLE risk in the ILE population.
Authors
- Vernon M. Chinchilli (ORCID: https://orcid.org/0000-0001-6488-7809)
- Benjamin F. Chong (ORCID: https://orcid.org/0000-0002-4092-7658)
- David R. Karp (ORCID: https://orcid.org/0000-0002-9005-1690)
- Cristina Arriens (ORCID: https://orcid.org/0000-0002-9546-1664)
- Joel M. Guthridge (ORCID: https://orcid.org/0000-0002-9308-237X)
- Nancy J. Olsen (ORCID: https://orcid.org/0000-0002-6588-3364)
- Élise Schaefer (ORCID: https://orcid.org/0000-0003-1004-6814)
- Christopher C. Striebich (ORCID: https://orcid.org/0000-0003-2582-7752)
- Fan He (ORCID: https://orcid.org/0000-0002-4145-9999)
- Sonali Narain (ORCID: https://orcid.org/0000-0002-6686-9441)
- Duanping Liao (ORCID: https://orcid.org/0000-0001-7405-6152)
- Diane L. Kamen (ORCID: https://orcid.org/0000-0002-7698-980X)
- Judith A. James (ORCID: https://orcid.org/0000-0002-9574-7355)
- Mariko Ishimori
- Daniel J. Wallace
Institutions
- Cedars-Sinai Medical Center (US)
- Pennsylvania State University (US)
- Medical University of South Carolina (US)
- Oklahoma Medical Research Foundation (US)
- Donald & Barbara Zucker School of Medicine at Hofstra/Northwell (US)
- Department of Public Health (MM)
- University of Colorado Anschutz Medical Campus (US)
- Penn State Milton S. Hershey Medical Center (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Arthritis & Rheumatology
- Published
- 2025-09-16
- DOI
- https://doi.org/10.1002/art.43391
- Citations
- 3
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 5.00
Funders
- National Institutes of Health
- National Institute of General Medical Sciences
- National Center for Advancing Translational Sciences